Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
House of Representatives, Congress."
House Hearing, 117th Congress
- HEARING ON; FDA USER FEE REAUTHORIZATION: ENSURING SAFE AND EFFECTIVE DRUGS AND BIOLOGICS. Government. U.S. Government Publishing Office https://www.govinfo.gov/app/details/CHRG-117hhrg57563.
APA
House of Representatives, Congress. (2022, February 3). Serial No. 117-65 - HEARING ON; FDA USER FEE REAUTHORIZATION: ENSURING SAFE AND EFFECTIVE DRUGS AND BIOLOGICS. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/CHRG-117hhrg57563
MLA
House of Representatives, Congress. Serial No. 117-65 - HEARING ON; FDA USER FEE REAUTHORIZATION: ENSURING SAFE AND EFFECTIVE DRUGS AND BIOLOGICS. U.S. Government Publishing Office, (3 Feb 2022), https://www.govinfo.gov/app/details/CHRG-117hhrg57563
Bluebook
House of Representatives, Congress, HEARING ON; FDA USER FEE REAUTHORIZATION: ENSURING SAFE AND EFFECTIVE DRUGS AND BIOLOGICS, GovInfo, (February 3, 2022), https://www.govinfo.gov/app/details/CHRG-117hhrg57563
